Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Quijano Rubio

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cell Death Discovery|July 29, 2022
CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent mannerClara Quijano-Rubio, Manuela Silginer, Michael Weller
Journal of Neuro-Oncology|November 10, 2022
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma modelsClara Quijano-Rubio, Manuela Silginer, Michael Weller
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersImke Kirste, David Caley, Clara Quijano Rubio, et al.
Cell Death & Disease|January 24, 2020
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancerJing Ma, Mohanraj Ramachandran, Chuan Jin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Neurology and Therapy|July 20, 2025
Clinical Performance of the Elecsys CSF pTau<sub>181</sub>/Aβ<sub>42</sub> Ratio for Concordance with Tau-PET in Two Independent CohortsRuben Smith, Leslie Shaw, Sebastian Palmqvist, et al.
Alzheimer'S Research & Therapy|June 22, 2024
Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkersAnna Orduña Dolado, Erik Stomrud, Nicholas J Ashton, et al.
Frontiers in Aging Neuroscience|June 14, 2024
Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer's continuumDavid López-Martos, Marc Suárez-Calvet, Marta Milà-Alomà, et al.
Brain Pathology (Zurich, Switzerland)|June 7, 2026
Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathologySelvi Ince, Carol Van Hulle, Gwendlyn Kollmorgen, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cell Death Discovery|July 29, 2022
CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent mannerClara Quijano-Rubio, Manuela Silginer, Michael Weller
Journal of Neuro-Oncology|November 10, 2022
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma modelsClara Quijano-Rubio, Manuela Silginer, Michael Weller
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersImke Kirste, David Caley, Clara Quijano Rubio, et al.
Cell Death & Disease|January 24, 2020
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancerJing Ma, Mohanraj Ramachandran, Chuan Jin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Neurology and Therapy|July 20, 2025
Clinical Performance of the Elecsys CSF pTau<sub>181</sub>/Aβ<sub>42</sub> Ratio for Concordance with Tau-PET in Two Independent CohortsRuben Smith, Leslie Shaw, Sebastian Palmqvist, et al.
Alzheimer'S Research & Therapy|June 22, 2024
Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkersAnna Orduña Dolado, Erik Stomrud, Nicholas J Ashton, et al.
Frontiers in Aging Neuroscience|June 14, 2024
Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer's continuumDavid López-Martos, Marc Suárez-Calvet, Marta Milà-Alomà, et al.
Brain Pathology (Zurich, Switzerland)|June 7, 2026
Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathologySelvi Ince, Carol Van Hulle, Gwendlyn Kollmorgen, et al.
Pageof 5